Design, Synthesis, SAR Study, Antimicrobial and Anticancer Evaluation of Novel 2-Mercaptobenzimidazole Azomethine Derivatives

Author(s): Sumit Tahlan, Balasubramanian Narasimhan*, Siong Meng Lim, Kalavathy Ramasamy, Vasudevan Mani, Syed Adnan Ali Shah

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 20 , Issue 15 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Various analogues of benzimidazole are found to be biologically and therapeutically potent against several ailments. Benzimidazole when attached with heterocyclic rings has shown wide range of potential activities. So, from the above provided facts, we altered benzimidazole derivatives so that more potent antagonists could be developed. In the search for a new category of antimicrobial and anticancer agents, novel azomethine of 2-mercaptobenzimidazole derived from 3-(2- (1H-benzo[d]imidazol-2-ylthio)acetamido)benzohydrazide were synthesized.

Results and Discussion: The synthesized analogues were characterized by FT-IR, 1H/13C-NMR and MS studies as well C, H, N analysis. All synthesized compounds were evaluated for in vitro antibacterial activity against Gram-positive (B. subtilis), Gram-negative (E. coli, P. aeruginosa, K. pneumoniae and S. typhi) strains and in vitro antifungal activity against C. albicans and A. niger strains by serial dilution method, the minimum inhibitory concentration (MIC) described in μM/ml. The in vitro anticancer activity of synthesized compounds was determined against human colorectal carcinoma cell line (HCT- 116) using 5-fluorouracil as standard drug.

Conclusion: In general, most of the synthesized derivatives exhibited significant antimicrobial and anticancer activities. Compounds 8, 10, 15, 16, 17, 20 and 22 showed significant antimicrobial activity towards tested bacterial and fungal strains and compound 26 exhibited significant anticancer activity.

Keywords: 3-Aminobenzoic acid, antibacterial, anticancer, antifungal, 2-Mercaptobenzimidazole azomethine derivatives, Minimum inhibitory concentration, SAR.

[1]
Salahuddin; Shaharyar, M.; Mazumder, A.; Ahsan, M.J. Synthesis, characterization and anticancer evaluation of 2-(naphthalen-1-ylmethyl/naphthalen-2-yloxymethyl)-1-[5-(substituted phenyl) [1,3,4]oxadiazol-2-ylmethyl]-1H-benzimidazole. Arab. J. Chem., 2014, 7, 418-424.
[2]
Sharma, M.C. QSAR studies of novel1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acidderivatives and their precursors as antileukaemic agents. J. Taibah Uni. Sci., 2015, 10, 122-130.
[3]
Padalkar, V.S.; Borse, B.N.; Gupta, V.D.; Phatangare, K.R.; Patil, V.S.; Umape, P.G.; Sekar, N. Synthesis and antimicrobial activity of novel 2-substituted benzimidazole, benzoxazole and benzothiazole derivatives. Arab. J. Chem., 2016, 9(2), S1125-S1130.
[4]
Ozkay, Y.; Tunali, Y.; Karaca, H.; Isikdag, I. Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety. Eur. J. Med. Chem., 2010, 45, 3293-3298.
[5]
Hosamani, K.M.; Shingalapur, R.V. Synthesis of 2-mercapto-benzimidazole derivatives as potential antimicrobial and cytotoxic agents. Arch. Pharm., 2011, 344(5), 311-339.
[6]
Kumar, P.; Narasimhan, B.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B.A. Synthesis, antimicrobial, anticancer Evaluation and QSAR studies of 3/4-bromo benzohydrazide derivatives. Curr. Top. Med. Chem., 2015, 15, 1050-1064.
[7]
Ranganatha, S.R.; Kavitha, C.V.; Vinaya, K.; Prasanna, D.S.; Chandrappa, S.; Sathees, C.R.; Rangappa, K.S. Synthesis and cytotoxic evaluation of novel 2-(4(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d] imidazole derivatives. Arch. Pharm. Res., 2009, 32(10), 1335-1343.
[8]
Yang, Y.H.; Cheng, M.S.; Wang, Q.H.; Nie, H.; Liao, N.; Wang, J.; Chen, H. Design, synthesis, and anti-tumor evaluation of novel symmetrical bis-benzimidazoles. Eur. J. Med. Chem., 2009, 44, 1808-1812.
[9]
Kumar, P.; Narasimhan, B.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B.A. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of 2/3-bromo-N′-(substituted benzylidene/ 3-phenylallylidene)benzohydrazides. Arab. J. Chem., 2017, 10, S3740-S3748.
[10]
Ayhan-Kilcigil, G.; Kus, C.; Ozdamar, E.D.; Can-Eke, B.; Iscan, M. Synthesis and antioxidant capacities of some new benzimidazole derivatives. Arch. Pharm. Chem. Life Sci., 2007, 340, 607-611.
[11]
Bhat, M.A.; Al-omar, M.A. Synthesis, characterization and in vivo anticonvulsant and neurotoxicity screening of Schiff bases of phthalimide. Acta Pol. Pharm., 2011, 68, 375-380.
[12]
Sondhi, S.M.; Singh, N.; Kumar, A.; Lozach, O.; Meijer, L. Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/ benzoxazole derivatives and some Schiff’s bases. Bioorg. Med. Chem., 2006, 14, 3758-3765.
[13]
Divatia, S.M.; Rajani, D.P.; Rajani, S.D.; Patel, H.D. Novel thiosemicarbazone derivatives containing benzimidazole moiety: Green synthesis and anti-malarial activity. Arab. J. Chem., 2014, . (in press)
[14]
Kalalbandi, V.K.A.; Seetharamappa, J.; Katrahalli, U.; Bhat, K.G. Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives. Eur. J. Med. Chem., 2014, 79, 194-202.
[15]
Kumar, P.; Narasimhan, B.; Yogeeswari, P.; Sriram, D. Synthesis and antitubercular activities of substituted benzoic acid N′-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides. Eur. J. Med. Chem., 2010, 45, 6085-6089.
[16]
Monforte, A.M.; Ferro, S.; Luca, L.D.; Surdo, G.L.; Morreale, F.; Pannecouque, C.; Balzarini, J.; Chimirri, A. Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem., 2014, 22, 1459-1467.
[17]
Mavrova, A.T.; Vuchev, D.; Anichina, K.; Vassilev, N. Synthesis, anti-trichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring. Eur. J. Med. Chem., 2010, 45, 5856-5861.
[18]
Gaba, M.; and Mohan, C. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: Recent advances and future directions. Med. Chem. Res., 2016, 25, 173-210.
[19]
Mahiwal, K.; Kumar, P.; Narasimhan, B. Synthesis, antimicrobial evaluation, ot-QSAR and mt-QSAR studies of 2-amino benzoic acid derivatives. Med. Chem. Res., 2012, 21, 293-307.
[20]
Desai, K.G.; Desai, K.R. Green route for the heterocyclization of 2-mercaptobenzimidazole into β-lactum segment derivatives containing –CONH– bridge with benzimidazole: Screening in vitro antimicrobial activity with various microorganisms. Bioorg. Med. Chem., 2006, 14(24), 8271-8279.
[21]
Kumar, P.; Narasimhan, B.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B.A.; Clercq, E.D. N′-[4-[(Substituted imino) methyl]benzylidene]-substituted benzohydrazides: Synthesis, antimicrobial, antiviral and anticancer evaluation, and QSAR studies. Monatsh. Chem., 2013, 144, 825-849.
[22]
Kaplancikli, Z.A.; Turan-Zitouni, G.; Revial, G.; Iscan, G. Synthesis of some dithiocarbamate derivatives and their antimicrobial activity. Phosphorus Sulfur Silicon., 2004, 179, 1449-1454.
[23]
Kaplancikli, Z.A.; Turan-Zitouni, G.; Revial, G.; Guven, K. Synthesis and study of antibacterial and antifungal activities of novel 2-[[(benzoxazole/benzimidazole-2-yl)sulfanyl]acetylamino] thiazoles. Arch. Pharm. Res., 2004, 27(11), 1081-1085.
[24]
Tahlan, S.; Kumar, P.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B.A.; Narasimhan, B. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of N′-substituted benzylidene/2-hydroxynaphthalen-1ylmethylene/3-phenyl allylidene/5-oxopentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)benzohydrazides. Arab. J. Chem., 2017, 10, S2009-S2017.
[25]
Cappuccino, J.G.; Sherman, N. In microbiology-a laboratory manual, 4th ed; 263, 1999.
[26]
Pharmacopoeia of India , vol I, Controller of publication, Ministry of Health Department, Govt. of India, New Delhi . 2007, , pp. 37.
[27]
Skehan, P.; Storeng Scudiero, R.D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-1112.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 15
Year: 2020
Published on: 15 October, 2020
Page: [1559 - 1571]
Pages: 13
DOI: 10.2174/1389557518666180903151849
Price: $65

Article Metrics

PDF: 19
HTML: 3